Ulotaront, a novel TAAR1 agonist with 5-HT1A agonist activity, lacks abuse liability and attenuates cocaine cue-induced relapse in rats

Authors:

Abstract
No abstract available
Funding Information
  • Sunovion Pharmaceuticals Inc

This publication has 42 references indexed in Scilit: